Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Compliance Of Medication After Discharge From the Hospital in the Elderly (COMADE)

2. april 2011 oppdatert av: William Beaumont Hospitals

Many elderly patients have multiple medications and variable dosing regimens and the ability for hospitals to properly reconcile medications between what is given on paper to the patient and what the patients take at home depends on the patient's ability to get the medications. Some patients may delay in getting their medications from the pharmacy after being discharged. For some it may be a lack of transportation, others may feel too ill to travel and may not have family members who will be able to pick up the medications.

It is for these reasons the authors of this study want to inventory the medications that an elderly patient is being discharged on during a home visit and check on the actual prescriptions that a patient has at their house the following 1-2 days after discharge.

Studieoversikt

Status

Fullført

Forhold

Detaljert beskrivelse

The goal is to evaluate the effectiveness of discharge instruction in the elderly by assessing medication compliance post-discharge. Patients are identified on the units and from a Beaumont Troy discharge planning master list. Prior to discharge the patients are consented and informed they will be contacted to schedule a home visit. During the home visit, the medications the patient is currently taking are recorded. Discharge medications are recorded from the medical record following the home visit. The Investigator performing the visit is blinded to the discharge medications as the intent of the visit is only to collect data and not to ensure compliance or make clinical judgment regarding the appropriateness of the medication regimen. Anyone 65 or older can be included, who are discharged with medications and can consent. Those excluded are patients who do not live in close proximity and those discharged to extended or long-term care facilities.

Studietype

Observasjonsmessig

Registrering (Forventet)

200

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

Forente stater
- Michigan
  - Royal Oak, Michigan, Forente stater, 48073
    - William Beaumont Hospital
  - Troy, Michigan, Forente stater, 48314
    - William Beaumont Hospital

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

65 år og eldre (Eldre voksen)

Tar imot friske frivillige

Kjønn som er kvalifisert for studier

Alle

Prøvetakingsmetode

Sannsynlighetsprøve

Studiepopulasjon

All patients over the age of 65 who are discharged home from the hospital who meet the eligibilty criteria.

Beskrivelse

Inclusion Criteria:

Elderly patients (age 65 or older)
Able to make own decisions (Patient has autonomy) and therefore able to make informed decisions
Patients with medications upon discharge from the hospital

Exclusion Criteria:

Patients that have the inability to give informed consent secondary to: cognitive disabilities, inability to speak or write or refusal to participate in study.
Patients that are younger than the age of 65.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

Hva måler studien?

Primære resultatmål

Resultatmål	Tidsramme
To observe compliance of medications from a discharge medication list to the meds at home after discharge from the hospital. Tidsramme: 18 months	18 months

Sekundære resultatmål

Resultatmål	Tidsramme
To observe if there are secondary factors that affect compliance (i.e. age of the patients, number of medications or herbal medications) Tidsramme: 18 months	18 months

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

William Beaumont Hospitals

Etterforskere

Hovedetterforsker: Jobin M Varughese, MD, William Beaumont Hospitals

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart

1. desember 2008

Primær fullføring (Faktiske)

1. mars 2010

Studiet fullført (Faktiske)

1. januar 2011

Datoer for studieregistrering

Først innsendt

18. november 2009

Først innsendt som oppfylte QC-kriteriene